Eurofins Scientific SE header image

Eurofins Scientific SE

ERF

Equity

ISIN FR0014000MR3 / Valor 58317129

Euronext - Euronext Paris (2026-06-29)
EUR 68.18-1.13%

Eurofins Scientific SE
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Eurofins Scientific SE is a prominent global entity in the bio-analytical testing sector, offering a wide array of services across various industries including food, environmental, pharmaceutical, and cosmetic product testing. The company is also recognized for its contributions to discovery pharmacology, forensics, advanced material sciences, agroscience contract research, genomics, clinical study support, BioPharma contract development and manufacturing, and specialty clinical diagnostic testing in Europe and the USA. With approximately 62,000 employees, Eurofins operates a vast network of over 1,000 companies in 62 countries, managing more than 900 laboratories. It provides over 200,000 analytical methods aimed at ensuring the safety, identity, composition, authenticity, origin, and purity of biological substances and products. Eurofins prides itself on delivering high-quality services, accurate results, and expert advice through its highly qualified staff, leveraging the latest developments in biotechnology and analytical chemistry to meet the rigorous quality and safety standards of its clients and regulatory authorities worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

12.0%1Y
20.7%3Y
-30.0%5Y

Performance

27.6%1Y
30.6%3Y
32.0%5Y

Volatility

Market cap

13726 M

Market cap (USD)

Daily traded volume (Shares)

244,605

Daily traded volume (Shares)

1 day high/low

49.2 / 48.54

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Valor: 129508879
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%DKK 314.90
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.15%EUR 17.16
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.62%USD 33.39
Sandoz Group Ltd
Sandoz Group Ltd Sandoz Group Ltd Valor: 124359842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.84%CHF 73.20
Aurora Cannabis Inc
Aurora Cannabis Inc Aurora Cannabis Inc Valor: 132838450
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.73%CAD 4.12
Douglas AG
Douglas AG Douglas AG Valor: 133507391
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%EUR 7.93
Galderma Group Ltd
Galderma Group Ltd Galderma Group Ltd Valor: 133539272
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.24%CHF 185.80
Emeis
Emeis Emeis Valor: 132546338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.69%EUR 13.82
Paul Hartmann AG
Paul Hartmann AG Paul Hartmann AG Valor: 1547181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 202.00
TransMedics Group Inc
TransMedics Group Inc TransMedics Group Inc Valor: 47361695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.68%USD 67.29